vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Madison Square Garden Entertainment Corp. (MSGE). Click either name above to swap in a different company.

Enovis CORP is the larger business by last-quarter revenue ($548.9M vs $424.8M, roughly 1.3× Madison Square Garden Entertainment Corp.). Madison Square Garden Entertainment Corp. runs the higher net margin — 21.8% vs -104.1%, a 125.9% gap on every dollar of revenue. On growth, Madison Square Garden Entertainment Corp. posted the faster year-over-year revenue change (12.5% vs -2.2%). Over the past eight quarters, Madison Square Garden Entertainment Corp.'s revenue compounded faster (48.9% CAGR vs 9.8%).

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

ENOV vs MSGE — Head-to-Head

Bigger by revenue
ENOV
ENOV
1.3× larger
ENOV
$548.9M
$424.8M
MSGE
Growing faster (revenue YoY)
MSGE
MSGE
+14.6% gap
MSGE
12.5%
-2.2%
ENOV
Higher net margin
MSGE
MSGE
125.9% more per $
MSGE
21.8%
-104.1%
ENOV
Faster 2-yr revenue CAGR
MSGE
MSGE
Annualised
MSGE
48.9%
9.8%
ENOV

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ENOV
ENOV
MSGE
MSGE
Revenue
$548.9M
$424.8M
Net Profit
$-571.1M
$92.7M
Gross Margin
59.9%
Operating Margin
-101.7%
38.6%
Net Margin
-104.1%
21.8%
Revenue YoY
-2.2%
12.5%
Net Profit YoY
18.8%
22.2%
EPS (diluted)
$-9.99
$1.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
MSGE
MSGE
Q4 25
$548.9M
$424.8M
Q3 25
$564.5M
$154.1M
Q2 25
$558.8M
$145.1M
Q1 25
$206.0M
Q4 24
$561.0M
$377.6M
Q3 24
$505.2M
$134.1M
Q2 24
$525.2M
$177.6M
Q1 24
$516.3M
$191.6M
Net Profit
ENOV
ENOV
MSGE
MSGE
Q4 25
$-571.1M
$92.7M
Q3 25
$-36.7M
$-21.7M
Q2 25
$-56.0M
$-27.2M
Q1 25
$8.0M
Q4 24
$-703.2M
$75.9M
Q3 24
$-31.5M
$-19.3M
Q2 24
$-18.6M
$66.9M
Q1 24
$-72.0M
$2.8M
Gross Margin
ENOV
ENOV
MSGE
MSGE
Q4 25
59.9%
Q3 25
59.3%
Q2 25
59.5%
Q1 25
Q4 24
54.8%
Q3 24
56.7%
Q2 24
55.0%
Q1 24
57.7%
Operating Margin
ENOV
ENOV
MSGE
MSGE
Q4 25
-101.7%
38.6%
Q3 25
-3.0%
-19.3%
Q2 25
-8.4%
-17.7%
Q1 25
13.3%
Q4 24
-118.5%
36.8%
Q3 24
-6.3%
-13.8%
Q2 24
-8.4%
-5.0%
Q1 24
-6.8%
8.8%
Net Margin
ENOV
ENOV
MSGE
MSGE
Q4 25
-104.1%
21.8%
Q3 25
-6.5%
-14.0%
Q2 25
-10.0%
-18.7%
Q1 25
3.9%
Q4 24
-125.4%
20.1%
Q3 24
-6.2%
-14.4%
Q2 24
-3.5%
37.7%
Q1 24
-13.9%
1.5%
EPS (diluted)
ENOV
ENOV
MSGE
MSGE
Q4 25
$-9.99
$1.94
Q3 25
$-0.64
$-0.46
Q2 25
$-0.98
$-0.56
Q1 25
$0.17
Q4 24
$-12.69
$1.56
Q3 24
$-0.58
$-0.40
Q2 24
$-0.34
$1.32
Q1 24
$-1.32
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
MSGE
MSGE
Cash + ST InvestmentsLiquidity on hand
$33.6M
$157.1M
Total DebtLower is stronger
$1.4B
$554.6M
Stockholders' EquityBook value
$2.0B
$36.0M
Total Assets
$4.4B
$1.8B
Debt / EquityLower = less leverage
0.67×
15.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
MSGE
MSGE
Q4 25
$33.6M
$157.1M
Q3 25
$44.1M
$29.9M
Q2 25
$38.5M
$43.0M
Q1 25
$89.0M
Q4 24
$48.2M
$54.9M
Q3 24
$35.4M
$37.3M
Q2 24
$35.0M
$33.3M
Q1 24
$66.3M
$28.0M
Total Debt
ENOV
ENOV
MSGE
MSGE
Q4 25
$1.4B
$554.6M
Q3 25
$1.4B
$581.7M
Q2 25
$1.4B
$568.8M
Q1 25
$577.4M
Q4 24
$1.3B
$584.7M
Q3 24
$1.3B
$647.0M
Q2 24
$1.3B
$599.2M
Q1 24
$1.3B
$602.5M
Stockholders' Equity
ENOV
ENOV
MSGE
MSGE
Q4 25
$2.0B
$36.0M
Q3 25
$2.6B
$-65.8M
Q2 25
$2.6B
$-13.3M
Q1 25
$9.5M
Q4 24
$2.6B
$10.3M
Q3 24
$3.3B
$-48.7M
Q2 24
$3.3B
$-23.2M
Q1 24
$3.3B
$-94.6M
Total Assets
ENOV
ENOV
MSGE
MSGE
Q4 25
$4.4B
$1.8B
Q3 25
$5.0B
$1.7B
Q2 25
$4.9B
$1.7B
Q1 25
$1.7B
Q4 24
$4.7B
$1.6B
Q3 24
$5.6B
$1.6B
Q2 24
$5.4B
$1.6B
Q1 24
$5.5B
$1.5B
Debt / Equity
ENOV
ENOV
MSGE
MSGE
Q4 25
0.67×
15.40×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
60.61×
Q4 24
0.52×
56.61×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
MSGE
MSGE
Operating Cash FlowLast quarter
$82.6M
$164.4M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
1.77×
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
MSGE
MSGE
Q4 25
$82.6M
$164.4M
Q3 25
$47.8M
$19.8M
Q2 25
$-1.6M
$-27.0M
Q1 25
$56.8M
Q4 24
$88.3M
$112.9M
Q3 24
$53.6M
$-27.4M
Q2 24
$7.8M
$212.0K
Q1 24
$-36.2M
$5.8M
Free Cash Flow
ENOV
ENOV
MSGE
MSGE
Q4 25
$29.1M
Q3 25
$3.4M
Q2 25
$-44.9M
Q1 25
Q4 24
$35.1M
Q3 24
$2.4M
Q2 24
$-31.6M
Q1 24
$-73.1M
FCF Margin
ENOV
ENOV
MSGE
MSGE
Q4 25
5.3%
Q3 25
0.6%
Q2 25
-8.0%
Q1 25
Q4 24
6.3%
Q3 24
0.5%
Q2 24
-6.0%
Q1 24
-14.2%
Capex Intensity
ENOV
ENOV
MSGE
MSGE
Q4 25
9.7%
Q3 25
7.9%
Q2 25
7.7%
Q1 25
Q4 24
9.5%
Q3 24
10.1%
Q2 24
7.5%
Q1 24
7.2%
Cash Conversion
ENOV
ENOV
MSGE
MSGE
Q4 25
1.77×
Q3 25
Q2 25
Q1 25
7.07×
Q4 24
1.49×
Q3 24
Q2 24
0.00×
Q1 24
2.08×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

MSGE
MSGE

Ticketing And Venue License Fee Revenues$263.5M62%
Food Beverage And Merchandise Revenues$64.3M15%
Related Party$43.9M10%
Arena Licensing Fees And Other Leasing Revenue$35.2M8%
Other$15.9M4%

Related Comparisons